Navigation Links
IntelliVue MP90

ProductsIntelliVue MP90
Company Philips Medical Systems
Item IntelliVue MP90
Features 
  • Compact, quiet CPU
  • Portal technology
  • Up to 12 waveforms
  • Users choice of up to two independent configurable displays and up to two slave displays
  • Touchscreen, mouse, or PS-2 compatible screen navigation
  • Remote SpeedPoint for easy data entry and navigation
  • Two integrated Flexible Module Servers
  • Networked patient monitor with portal technology for highest intensity care
  • Highest performance monitoring for critical care
  • The Multi-Measurement Server: All-in-one convenience
  • Clinical Measurements: An ever expanding range
  • Description The IntelliVue MP90 is designed to match the pace and unique needs of the highest acuity care environments. Built on Philips strong heritage in patient monitoring, the IntelliVue MP90 with dual independent displays has highly flexible screen configuration; an extensive clinical measurements menu; built-in clinical support tools such as Event Surveillance, EASI derived 12-lead ECG, and arrhythmia analysis; and many other powerful features.

    IntelliVue is easy to use and operates on a networked platform that can span the hospital enterprise. It can be configured to suit patient acuity, department protocols, or specific procedure requirements.

    IntelliVue MP90 patient monitor is designed to match the pace and unique needs of:
  • Adult, pediatric, and neonatal intensive care
  • Anesthesia and peri-operative care
  • Cardiac care environments
  • Info Philips Medical SystemsCall Philips Medical Systems to buy products (US and Canada only; other locations use number below) USACanada1-866-745-0519

    Customer Service: 1-800-722-7900
    Web site: http://www.medical.philips.com/

    Related medicine products :

    1. IntelliVue MP60
    2. IntelliVue MP70
    3. IntelliVue MP40
    4. IntelliVue MP50
    5. IntelliVue MP20 Junior
    6. IntelliVue Information Center
    For the quantitative in vitro determination of Total Protein in serum and plasma...
    The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
    Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of Rheumatoid Factor in serum....
    For the quantitative in vitro determination of Carbon Dioxide in serum and plasma....
    Medicine Products:
    (Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
    (Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
    (Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
    (Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
    (Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
    Breaking Medicine News(10 mins):
    (Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
    (Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
    (Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
    Breaking Medicine Technology: